Daan Gene Co. Stock Hits Day Low of CNY 6.15 Amid Price Pressure

Daan Gene Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 6.26%. The stock reached an intraday low of CNY 6.15, reflecting ongoing challenges in its market performance. Over the past week, Daan Gene has seen a decline of 9.76%, contrasting sharply with the China Shanghai Composite, which fell by only 1.7%. In the longer term, the company has struggled, with a three-year performance decline of 48.57% and a staggering 72.82% drop over the past five years. Despite a modest one-year return of 10.36%, this figure pales in comparison to the 21.74% return of the China Shanghai Composite. The company's financial metrics indicate a concerning trend, with net sales decreasing at an annual rate of 27.73% and operating profit plummeting by 188.34% over the last five years. Additionally, Daan Gene's return on equity stands at -9.28%, further highlighting its current financial difficulties.